IGF2BP3 and breast carcinoma: Withaferin A-induced ROS inhibited hepatocellular carcinoma cell growth and migration through the inhibition of IGF2BP3 to deactivate JAK2/STAT3 signaling57, it can also inhibit breast cancer-induced osteoclast differentiation58.